These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 39031815)
21. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19. Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A; J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773 [TBL] [Abstract][Full Text] [Related]
22. Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study. Kiani P; Hendriksen PA; Kim AJ; Garssen J; Verster JC Viruses; 2024 Jun; 16(7):. PubMed ID: 39066194 [TBL] [Abstract][Full Text] [Related]
23. Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study. Kiran T; Craig-Neil A; Das P; Lockwood J; Wang R; Nathanielsz N; Rosenthal E; Snider C; Hwang SW CMAJ Open; 2021; 9(1):E302-E308. PubMed ID: 33785478 [TBL] [Abstract][Full Text] [Related]
24. Viral Dynamics of the SARS-CoV-2 Omicron Variant in Pediatric Patients: A Prospective Cohort Study. Science M; Orkin J; Maguire B; Bitnun A; Bourns L; Corbeil A; Johnstone J; Macdonald L; Schwartz KL; Bruce Barrett C; Reinprecht J; Heisey A; Nasso S; Jüni P; Campigotto A Clin Infect Dis; 2024 Jun; 78(6):1506-1513. PubMed ID: 38084906 [TBL] [Abstract][Full Text] [Related]
25. Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020. Rolfes MA; Grijalva CG; Zhu Y; McLean HQ; Hanson KE; Belongia EA; Halasa NB; Kim A; Meece J; Reed C; Talbot HK; Fry AM MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1633-1637. PubMed ID: 33382676 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study. Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922 [TBL] [Abstract][Full Text] [Related]
27. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472 [TBL] [Abstract][Full Text] [Related]
28. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457 [TBL] [Abstract][Full Text] [Related]
29. Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial. de Gabory L; Vallet S; Naelten G; Raherison-Semjen C Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3625-3637. PubMed ID: 38376591 [TBL] [Abstract][Full Text] [Related]
30. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study. Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting. Chung E; Chow EJ; Wilcox NC; Burstein R; Brandstetter E; Han PD; Fay K; Pfau B; Adler A; Lacombe K; Lockwood CM; Uyeki TM; Shendure J; Duchin JS; Rieder MJ; Nickerson DA; Boeckh M; Famulare M; Hughes JP; Starita LM; Bedford T; Englund JA; Chu HY JAMA Pediatr; 2021 Oct; 175(10):e212025. PubMed ID: 34115094 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting. Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Rapid Antigen Detection Test for Diagnosing SARS-CoV-2 during the COVID-19 Pandemic: Experience from a Centralized Isolation Site in Shanghai, China. Zhong X; Zhang L; Ma D; Shi Y; Wu J; Xu X; Chen W; Wu B; Tang Y; Qu H; Xie Q; Yang Y; Liu J; Xin H Microbiol Spectr; 2023 Feb; 11(1):e0454222. PubMed ID: 36655994 [TBL] [Abstract][Full Text] [Related]
35. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study. O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415 [TBL] [Abstract][Full Text] [Related]
36. Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing. Zhang J; Li K; Zheng L; Zhang J; Ren Z; Song T; Yu H; Yang Z; Wang L; Jiang L Front Cell Infect Microbiol; 2020; 10():558472. PubMed ID: 33415083 [TBL] [Abstract][Full Text] [Related]
37. A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time. Yousaf AR; Duca LM; Chu V; Reses HE; Fajans M; Rabold EM; Laws RL; Gharpure R; Matanock A; Wadhwa A; Pomeroy M; Njuguna H; Fox G; Binder AM; Christiansen A; Freeman B; Gregory C; Tran CH; Owusu D; Ye D; Dietrich E; Pevzner E; Conners EE; Pray I; Rispens J; Vuong J; Christensen K; Banks M; O'Hegarty M; Mills L; Lester S; Thornburg NJ; Lewis N; Dawson P; Marcenac P; Salvatore P; Chancey RJ; Fields V; Buono S; Yin S; Gerber S; Kiphibane T; Dasu T; Bhattacharyya S; Westergaard R; Dunn A; Hall AJ; Fry AM; Tate JE; Kirking HL; Nabity S Clin Infect Dis; 2021 Oct; 73(7):e1841-e1849. PubMed ID: 32719874 [TBL] [Abstract][Full Text] [Related]
38. Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period. Jang S; Rhee JY; Wi YM; Jung BK Int J Infect Dis; 2021 Jan; 102():561-565. PubMed ID: 33160066 [TBL] [Abstract][Full Text] [Related]
39. Prevalence, Patterns, and Predictors of SARS-CoV-2 RNA and Culturable Virus in Tears of a Case-Ascertained Household Cohort. So M; Goldberg SA; Lu S; Garcia-Knight M; Davidson MC; Tassetto M; Murray VW; Anglin K; Pineda-Ramirez J; Chen JY; Rugart PR; Richardson ET; Briggs-Hagen M; Midgley CM; Andino R; Seitzman GD; Gonzales J; Peluso MJ; Martin JN; Kelly JD Am J Ophthalmol; 2024 Sep; 265():48-53. PubMed ID: 38663502 [TBL] [Abstract][Full Text] [Related]
40. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T; Trials; 2021 May; 22(1):343. PubMed ID: 34001215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]